History of DPHARM
It was a daunting task to develop the first industry forum on thinking radically differently about the way we perform clinical trials, but the result was this conference. The event was launched in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.
The first DPHARM addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas. By the time the 2nd annual DPHARM program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them.
Fast forward to 2022, the 12th annual program will cover the full spectrum of clinical research, challenge how we can be radically more efficient in managing clinical operations, reduce patient and physician burden to participate in research, and thrive through a digital transformation. DPHARM 2022 is excited to be back in-person and expects to attract over 700 attendees.
We will include both industry and out-of-industry keynotes. We will feature more than 20 pharma companies, who will report on specific innovations they’ve been working on over the past 12 months to better deliver medicines.
DPHARM 2022 will provide a wide choice of tracks from AI/machine learning, voice technologies, new frontiers in digital and data science, DCTs, clinical research as a care option and more. DPHARM underscores the promise and challenge of innovation in advancing drug development.
